Prevention of Alzheimer’s Disease and Alzheimer’s Dementia

  • Tom C. Russ
  • Craig W. Ritchie
  • Karen Ritchie
Reference work entry
Part of the Mental Health and Illness Worldwide book series (MHIW)


This chapter will consider the prevention of dementia. The often neglected distinction between Alzheimer’s disease and Alzheimer’s dementia (and the formal inclusion of this distinction in the 2011 diagnostic criteria) will form our main focus, and, in particular, the consequent relevance of the life course paradigm in epidemiology that influences from any stage of life could potentially increase or decrease one’s risk of dementia. We will consider a number of risk factors for Alzheimer’s disease (i.e., primary prevention) including early life factors, intelligence and education, proxies for early life factors, midlife risk factors, multiple risk factors, and environmental factors. In considering prevention of Alzheimer’s dementia (i.e., secondary prevention), we will consider the relevance of the theory of cognitive or brain reserve. We will briefly consider attempts at disease modification in dementia (i.e., tertiary prevention) and the multiple trial failures seen in recent decades. After outlining the policy context, we will consider two important prevention initiatives: the PREVENT program and the European Prevention of Alzheimer’s Dementia (EPAD) project.


Prevention Alzheimer’s disease Alzheimer’s dementia Delirium Depression 


  1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279PubMedPubMedCentralCrossRefGoogle Scholar
  2. Annweiler C, Llewellyn DJ, Beauchet O (2013) Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 33:659–674PubMedGoogle Scholar
  3. Annweiler C, Dursun E, Feron F, Gezen-Ak D, Kalueff AV, Littlejohns T, Llewellyn DJ, Millet P, Scott T, Tucker KL, Yilmazer S, Beauchet O (2015) ‘Vitamin D and cognition in older adults’: updated international recommendations. J Intern Med 277:45–57PubMedCrossRefGoogle Scholar
  4. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631PubMedCrossRefGoogle Scholar
  5. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NME, Romano DM, Hartshorn MA, Tanzi RE, Bush AI (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273:12817–12826PubMedCrossRefGoogle Scholar
  6. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P (2012) Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 79:1397–1405PubMedPubMedCentralCrossRefGoogle Scholar
  7. Barker DJ (1990) The fetal and infant origins of adult disease. BMJ 301:1111–1111PubMedPubMedCentralCrossRefGoogle Scholar
  8. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 10:819–828PubMedPubMedCentralCrossRefGoogle Scholar
  9. Batty GD, Lawlor DA, Macintyre S, Clark H, Leon DA (2005) Accuracy of adults’ recall of childhood social class: findings from the Aberdeen children of the 1950s study. J Epidemiol Community Health 59:898–903PubMedPubMedCentralCrossRefGoogle Scholar
  10. Batty GD, Shipley MJ, Langenberg C, Marmot MG, Davey Smith G (2006) Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 17:157–166PubMedCrossRefGoogle Scholar
  11. Bennett D, Schneider J, Arvanitakis Z, Kelly J, Aggarwal N, Shah R, Wilson R (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837–1844PubMedCrossRefGoogle Scholar
  12. Ben-Shlomo Y, Kuh D (2002) A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 31:285–293PubMedCrossRefGoogle Scholar
  13. Berr C, Arnaud J, Akbaraly TN (2012) Selenium and cognitive impairment: a brief-review based on results from the EVA study. Biofactors 38:139–144PubMedCrossRefGoogle Scholar
  14. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRefGoogle Scholar
  15. Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351–357PubMedCrossRefGoogle Scholar
  16. Braak H, Del Tredici K (2010) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121:171–181PubMedCrossRefGoogle Scholar
  17. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969PubMedCrossRefGoogle Scholar
  18. Brayne C (2007) The elephant in the room – healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 8:233–239PubMedCrossRefGoogle Scholar
  19. Brookmeyer R, Gray S, Kawas C (1998) Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88:1337–1342PubMedPubMedCentralCrossRefGoogle Scholar
  20. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3:186–191PubMedCrossRefGoogle Scholar
  21. Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, Llewellyn DJ, Stoecklin E, Dierkes J, Kies AK, Kok FJ, Lamberg-Allardt C, Moser U, Pilz S, Saris WH, van Schoor NM, Weber P, Witkamp R, Zittermann A, de Groot LC (2013) Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int 24:1567–1577PubMedCrossRefGoogle Scholar
  22. Calkins K, Devaskar SU (2011) Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care 41:158–176PubMedPubMedCentralCrossRefGoogle Scholar
  23. Chen JC, Wang X, Wellenius GA, Serre ML, Driscoll I, Casanova R, McArdle JJ, Manson JE, Chui HC, Espeland MA (2015) Ambient air pollution and neurotoxicity on brain structure: evidence from women’s health initiative memory study. Ann Neurol 78:466–476PubMedPubMedCentralCrossRefGoogle Scholar
  24. Clifford A, Lang L, Chen R, Anstey KJ, Seaton A (2016) Exposure to air pollution and cognitive functioning across the life course–a systematic literature review. Environ Res 147:383–398PubMedCrossRefGoogle Scholar
  25. Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M (2010b) NIH state-of-the-science conference statement: preventing Alzheimer’s disease and cognitive decline. NIH Consens State Sci Statements 27:1–30PubMedGoogle Scholar
  26. Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly JES, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M (2010a) National Institutes of Health State-of-the-Science Conference Statement: preventing Alzheimer disease* and cognitive decline. Ann Intern Med 153:176–181PubMedCrossRefGoogle Scholar
  27. Deary IJ, Whalley LJ, Starr JM (2009) A lifetime of intelligence: the Scottish Mental Surveys of 1932 and 1947. American Psychological Association, Washington, DCCrossRefGoogle Scholar
  28. Deary IJ, Gow AJ, Pattie A, Starr JM (2012) Cohort profile: the Lothian Birth Cohorts of 1921 and 1936. Int J Epidemiol 41:1576–1584PubMedCrossRefGoogle Scholar
  29. Dodge HH, Buracchio TJ, Fisher GG, Kiyohara Y, Meguro K, Tanizaki Y, Kaye JA (2012) Trends in the prevalence of dementia in Japan. Int J Alzheimer’s Dis 2012:956354Google Scholar
  30. Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med 370:311–321PubMedCrossRefGoogle Scholar
  31. Flaten TP (2001) Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull 55:187–196PubMedCrossRefGoogle Scholar
  32. Gauthier S, Patterson C, Gordon M, Soucy J-P, Schubert F, Leuzy A (2011) Commentary on “Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.” A Canadian perspective. Alzheimers Dement 7:330–332PubMedCrossRefGoogle Scholar
  33. Gustafson DR, Backman K, Joas E, Waern M, Ostling S, Guo X, Skoog I (2012) 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden. J Alzheimers Dis 28:163–171PubMedGoogle Scholar
  34. Herrup K (2011) Commentary on “Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.” Addressing the challenge of Alzheimer’s disease in the 21st century. Alzheimers Dement 7:335–337PubMedCrossRefGoogle Scholar
  35. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:257–262PubMedPubMedCentralCrossRefGoogle Scholar
  36. Jansen WJ, Ossenkoppele R, Knol DL et al (2015) Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313:1924–1938PubMedPubMedCentralCrossRefGoogle Scholar
  37. Joas E, Backman K, Gustafson D, Ostling S, Waern M, Guo X, Skoog I (2012) Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension 59:796–801PubMedCrossRefGoogle Scholar
  38. Khachaturian ZS (2011) Revised criteria for diagnosis of Alzheimer’s disease: National Institute on Aging-Alzheimer’s Association diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:253–256PubMedCrossRefGoogle Scholar
  39. Killin LOJ, Starr JM, Shiue IJ, Russ TC (2016) Environmental risk factors for dementia: a systematic review. BMC Geriatr 16:175PubMedPubMedCentralCrossRefGoogle Scholar
  40. Kivimaki M, Singh-Manoux A, Shipley MJ, Elbaz A (2015) Does midlife obesity really lower dementia risk? Lancet Diabetes Endocrinol 3:498PubMedCrossRefGoogle Scholar
  41. Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, Lindstrom J, Mangialasche F, Nissinen A, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H (2013) The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement 9:657–665PubMedCrossRefGoogle Scholar
  42. Korczyn AD (2011) Commentary on “Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease”. Alzheimers Dement 7:333–334PubMedCrossRefGoogle Scholar
  43. Kuh D, Ben-Shlomo Y (2004) A life course approach to chronic disease epidemiology. Oxford University Press, OxfordCrossRefGoogle Scholar
  44. Langa KM (2015) Is the risk of Alzheimer’s disease and dementia declining? Alzheimers Res Ther 7:1CrossRefGoogle Scholar
  45. Langa KM, Larson EB, Karlawish JH, Cutler DM, Kabeto MU, Kim SY, Rosen AB (2008) Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement 4:134–144PubMedPubMedCentralCrossRefGoogle Scholar
  46. Lincoln P, Fenton K, Alessi C, Prince M, Brayne C, Wortmann M, Patel K, Deanfield J, Mwatsama M (2014) The Blackfriars Consensus on brain health and dementia. Lancet 383:1805–1806PubMedCrossRefGoogle Scholar
  47. Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Kos K, Soni M, Llewellyn DJ (2014) Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83:920–928PubMedPubMedCentralCrossRefGoogle Scholar
  48. Liu-Seifert H, Siemers E, Holdridge KC, Andersen SW, Lipkovich I, Carlson C, Sethuraman G, Hoog S, Hayduk R, Doody R, Aisen P (2015) Delayed-start analysis: Mild Alzheimer’s disease patients in solanezumab trials, 3.5 years. Alzheimer’s Dement: Transl Res Clin Interv 1:111–121Google Scholar
  49. Lobo A, Saz P, Marcos G, Dia J, De-la-Camara C, Ventura T, Montañes J, Lobo-Escolar A, Aznar S (2007) Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project. Acta Psychiatr Scand 116:299–307PubMedCrossRefGoogle Scholar
  50. Loef M, Schrauzer GN, Walach H (2011) Selenium and Alzheimer’s disease: a systematic review. J Alzheimers Dis 26:81–104PubMedGoogle Scholar
  51. Lyketsos CG (2011) Commentary on “Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease”. New Criteria New Era Alzheimer’s Dement 7:328–329CrossRefGoogle Scholar
  52. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer’s disease: clinical trials and drug development. Lancet Neurol 9:702–716PubMedCrossRefGoogle Scholar
  53. Manton K, Gu X, Ukraintseva S (2005) Declining prevalence of dementia in the US elderly population. Adv Gerontol 16Google Scholar
  54. Martyn C, Osmond C, Edwardson J, Barker D, Harris E, Lacey R (1989) Geographical relation between Alzheimer’s disease and aluminium in drinking water. Lancet 333:61–62CrossRefGoogle Scholar
  55. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, Brayne C, M. R. C. C. Function and A. Collaboration (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 382:1405–1412PubMedPubMedCentralCrossRefGoogle Scholar
  56. Matthews F, Stephan B, Robinson L, Jagger C, Barnes L, Arthur A, Brayne C, A. S. C. Collaboration (2016) A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun 7:11398PubMedPubMedCentralCrossRefGoogle Scholar
  57. McGuinness B, Todd S, Passmore P, Bullock R (2009) Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 4:CD004034Google Scholar
  58. McGuinness B, Craig D, Bullock R, Malouf R, Passmore P (2014) Statins for the treatment of dementia. Cochrane Database Syst Rev 7:CD007514Google Scholar
  59. McGurn B, Deary IJ, Starr JM (2008) Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia. Neurology 71:1051–1056PubMedCrossRefGoogle Scholar
  60. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–939PubMedCrossRefGoogle Scholar
  61. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269PubMedPubMedCentralCrossRefGoogle Scholar
  62. Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, Aggarwal NT (2015) MIND diet slows cognitive decline with aging. Alzheimers Dement 11:1015PubMedPubMedCentralCrossRefGoogle Scholar
  63. Muller M, Sigurdsson S, Kjartansson O, Jonsson PV, Garcia M, von Bonsdorff MB, Gunnarsdottir I, Thorsdottir I, Harris TB, van Buchem M, Gudnason V, Launer LJ (2014) Birth size and brain function 75 years later. Pediatrics 134:761–770PubMedPubMedCentralCrossRefGoogle Scholar
  64. Ngandu T, Lehtisalo J, Levalahti E, Laatikainen T, Lindstrom J, Peltonen M, Solomon A, Ahtiluoto S, Antikainen R, Hanninen T, Jula A, Mangialasche F, Paajanen T, Pajala S, Rauramaa R, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M (2014) Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-a randomized controlled lifestyle trial. Int J Environ Res Public Health 11:9345–9360PubMedPubMedCentralCrossRefGoogle Scholar
  65. Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385:2255–2263PubMedCrossRefGoogle Scholar
  66. Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, Walton J, Desai M, Solomon DF, Molena E, Worrall R, Hayen A, Choudhary P, Ladds E, Lanctot KL, Verhey FR, McCleery JM, Mead GE, Clare L, Fioravanti M, Hyde C, Marcus S, McShane R (2013) Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia. Alzheimers Dement 9:e96–e105PubMedCrossRefGoogle Scholar
  67. Norton MC, Østbye T, Smith KR, Munger RG, Tschanz JT (2009) Early parental death and late-life dementia risk: findings from the Cache County Study. Age Ageing 38:340. afp023PubMedPubMedCentralCrossRefGoogle Scholar
  68. Norton MC, Smith KR, Østbye T, Tschanz JAT, Schwartz S, Corcoran C, Breitner JC, Steffens DC, Skoog I, Rabins PV (2011) Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study. Am J Geriatr Psychiatry 19:814–824PubMedPubMedCentralCrossRefGoogle Scholar
  69. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C (2014) Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol 13:788–794PubMedCrossRefGoogle Scholar
  70. Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H (2016) CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol 15:673–684PubMedCrossRefGoogle Scholar
  71. Parkman H, Hultberg H (2002) Occurrence and effects of selenium in the environment – a literature review. IVL Swedish Environmental Research Institute, GöteborgGoogle Scholar
  72. Persson G, Skoog I (1996) A prospective population study of psychosocial risk factors for late onset dementia. Int J Geriatr Psychiatry 11:15–22CrossRefGoogle Scholar
  73. Plomin R, Daniels D (2011) Why are children in the same family so different from one another? Int J Epidemiol 40:563–582PubMedPubMedCentralCrossRefGoogle Scholar
  74. Prince M, Guerchet M, Prina M (2013) The global impact of dementia 2013–2050. Alzheimer’s Disease International, LondonGoogle Scholar
  75. Prince M, Albanese E, Guerchet M, Prina M (2014) World Alzheimer report 2014. Dementia and risk reduction: an analysis of protective and modifiable factors. Alzheimer Disease International, LondonGoogle Scholar
  76. Public Health England and UK Health Forum (2014) Blackfriars Consensus on promoting brain health: reducing risks for dementia in the population. UK Health Forum, LondonGoogle Scholar
  77. Qiu C, von Strauss E, Bäckman L, Winblad B, Fratiglioni L (2013) Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 80:1888–1894PubMedCrossRefGoogle Scholar
  78. Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, Evans SJ, Pocock SJ (2015) BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol 3:431–436PubMedCrossRefGoogle Scholar
  79. Randall C, Mosconi L, de Leon M, Glodzik L (2013) Cerebrospinal fluid biomarkers of Alzheimer’s disease in healthy elderly. Front Biosci (Landmark Ed) 18:1150–1173CrossRefGoogle Scholar
  80. Richard E, Van den Heuvel E, Moll van Charante EP, Achthoven L, Vermeulen M, Bindels PJ, Van Gool WA (2009) Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Dis Assoc Disord 23:198–204PubMedCrossRefGoogle Scholar
  81. Riley KP, Snowdon DA, Desrosiers MF, Markesbery WR (2005) Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging 26:341–347PubMedCrossRefGoogle Scholar
  82. Ritchie CW, Ritchie K (2012) The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer’s disease. BMJ Open 2Google Scholar
  83. Ritchie K, Carriere I, Ritchie C, Berr C, Artero S, Ancelin M-L (2010) Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 341:c3885PubMedPubMedCentralCrossRefGoogle Scholar
  84. Ritchie K, Jaussent I, Stewart R, Dupuy AM, Courtet P, Malafosse A, Ancelin ML (2011) Adverse childhood environment and late-life cognitive functioning. Int J Geriatr Psychiatry 26:503–510PubMedCrossRefGoogle Scholar
  85. Ritchie CW, Wells K, Ritchie K (2013) The PREVENT research programme – a novel research programme to identify and manage midlife risk for dementia: the conceptual framework. Int Rev Psychiatry 25:748–754PubMedCrossRefGoogle Scholar
  86. Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R (2014) Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 6:Cd008782Google Scholar
  87. Ritchie K, Ritchie CW, Jaffe K, Skoog I, Scarmeas N (2015) Is late-onset Alzheimer’s disease really a disease of midlife? Alzheimers Dement (NY) 1:122–130Google Scholar
  88. Ritchie CW, Molinuevo JL, Satlin A, Truyen L, van der Geyten S, Lovestone S (2016) Development of interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzheimer’s Dementia (EPAD) project. Lancet Psychiatry 3:179–186PubMedCrossRefGoogle Scholar
  89. Rocca WA, Petersen RC, Knopman DS, Hebert LE, Evans DA, Hall KS, Gao S, Unverzagt FW, Langa KM, Larson EB (2011) Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement 7:80–93PubMedPubMedCentralCrossRefGoogle Scholar
  90. Rosness TA, Strand BH, Engedal K, Chemali Z, Bjertness E (2015) What does height tell us about the risk of dementia? Int J Geriatr Psychiatry 30:776–777PubMedCrossRefGoogle Scholar
  91. Russ TC, Batty GD, Hearnshaw GF, Fenton C, Starr JM (2012) Geographical variation in dementia: systematic review with meta-analysis. Int J Epidemiol 41:1012–1032PubMedPubMedCentralCrossRefGoogle Scholar
  92. Russ TC, Kivimaki M, Starr JM, Stamatakis E, Batty GD (2014) Height in relation to dementia death: individual participant meta-analysis of 18 UK prospective cohort studies. Br J Psychiatry 205:348–354PubMedPubMedCentralCrossRefGoogle Scholar
  93. Russ TC, Gatz M, Pedersen NL, Hannah J, Wyper G, Batty GD, Deary IJ, Starr JM (2015a) Geographical variation in dementia: examining the role of environmental factors in Sweden and Scotland. Epidemiology 26:263–270PubMedPubMedCentralCrossRefGoogle Scholar
  94. Russ TC, Starr JM, Stamatakis E, Kivimaki M, Batty GD (2015b) Pulmonary function as a risk factor for dementia death: an individual participant meta-analysis of six UK general population cohort studies. J Epidemiol Community Health 69:550–556PubMedCrossRefGoogle Scholar
  95. Russ TC, Murianni L, Icaza G, Slachevsky A, Starr JM (2016) Geographical variation in dementia mortality in Italy, New Zealand, and Chile: the impact of latitude, vitamin D, and air pollution. Dement Geriatr Cogn Disord 42:31–41PubMedCrossRefGoogle Scholar
  96. Russ TC, Hannah J, Batty GD., Booth CC, Deary IJ, Starr JM (In Press) Childhood cognitive ability and incident dementia: the 1932 Scottish Mental Survey into their tenth decade. Epidemiology.Google Scholar
  97. Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M (2014) Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014. J Intern Med 275:251–283PubMedPubMedCentralCrossRefGoogle Scholar
  98. Schrijvers EM, Verhaaren BF, Koudstaal PJ, Hofman A, Ikram MA, Breteler MM (2012) Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 78:1456–1463PubMedCrossRefGoogle Scholar
  99. Scottish Council for Research in Education (1933) The intelligence of Scottish children: a national survey of an age-group. University of London Press, LondonGoogle Scholar
  100. Scottish Council for Research in Education (1949) The trend of Scottish intelligence: a comparison of the 1947 and 1932 surveys of the intelligence of eleven-year-old pupils. University of London Press, LondonGoogle Scholar
  101. Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O’Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (2016) The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537:50–56PubMedCrossRefGoogle Scholar
  102. Shenkin SD, Starr JM, Pattie A, Rush MA, Whalley LJ, Deary IJ (2001) Birth weight and cognitive function at age 11 years: the Scottish Mental Survey 1932. Arch Dis Child 85:189–196PubMedPubMedCentralCrossRefGoogle Scholar
  103. Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R (2016) Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer’s disease patients. Alzheimer’s Dement: J Alzheimer’s Assoc 12:110–120CrossRefGoogle Scholar
  104. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141–1145PubMedCrossRefGoogle Scholar
  105. Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C (2015) (18)F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 1:Cd010632PubMedGoogle Scholar
  106. Smith AD, Yaffe K (2014) Dementia (including Alzheimer’s disease) can be prevented: statement supported by international experts. J Alzheimers Dis 38:699–703PubMedGoogle Scholar
  107. Snowdon DA (2011) Aging with grace: the Nun Study and the science of old age. How we can all live longer, healthier and more vital lives. Fourth Estate, LondonGoogle Scholar
  108. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR (1996) Linguistic ability in early life and cognitive function and Alzheimer’s disease in late life. Findings from the Nun study. JAMA 275:528–532PubMedCrossRefGoogle Scholar
  109. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedPubMedCentralCrossRefGoogle Scholar
  110. Stern Y (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 11:1006–1012PubMedPubMedCentralCrossRefGoogle Scholar
  111. Stern Y, Alexander GE, Prohovnik I, Mayeux R (1992) Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer’s disease. Ann Neurol 32:371–375PubMedCrossRefGoogle Scholar
  112. Stern Y, Tang MX, Denaro J, Mayeux R (1995) Increased risk of mortality in Alzheimer’s disease patients with more advanced educational and occupational attainment. Ann Neurol 37:590–595PubMedCrossRefGoogle Scholar
  113. Stern Y, Albert S, Tang MX, Tsai WY (1999) Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology 53:1942–1947PubMedCrossRefGoogle Scholar
  114. Strand BH, Langballe EM, Rosness TA, Engedal K, Bjertness E (2015) Does midlife obesity really lower dementia risk? Lancet Diabetes Endocrinol 3:498–499PubMedCrossRefGoogle Scholar
  115. Valenzuela MJ, Sachdev P (2006) Brain reserve and dementia: a systematic review. Psychol Med 36:441–454PubMedCrossRefGoogle Scholar
  116. van Charante EPM, Richard E, Eurelings LS, van Dalen J-W, Ligthart SA, van Bussel EF, Hoevenaar-Blom MP, Vermeulen M, van Gool WA (2016) Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet 388:797–805Google Scholar
  117. van der Burg JM, Pijl H, Campman YJ, Roos RA, Aziz NA (2015) Does midlife obesity really lower dementia risk? Lancet Diabetes Endocrinol 3:499–500PubMedCrossRefGoogle Scholar
  118. Vaudano E, Vannieuwenhuyse B, Van Der Geyten S, van der Lei J, Visser PJ, Streffer J, Ritchie C, McHale D, Lovestone S, Hofmann-Apitius M, Truyen L, Goldman M (2015) Boosting translational research on Alzheimer’s disease in Europe: the innovative medicine initiative AD research platform. Alzheimers Dement 11:1121PubMedCrossRefGoogle Scholar
  119. Whalley LJ (2012) Spatial distribution and secular trends in the epidemiology of Alzheimer’s disease. Neuroimaging Clin N Am 22(1–10):viiGoogle Scholar
  120. Whalley LJ (2015) Understanding brain aging and dementia: a life course spproach. Columbia University Press, New YorkCrossRefGoogle Scholar
  121. Whalley LJ, Starr JM, Athawes R, Hunter D, Pattie A, Deary IJ (2000) Childhood mental ability and dementia. Neurology 55:1455–1459PubMedCrossRefGoogle Scholar
  122. Whalley LJ, Dick FD, McNeill G (2006) A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 5:87–96PubMedCrossRefGoogle Scholar
  123. Whalley LJ, Murray AD, Staff RT, Starr JM, Deary IJ, Fox HC, Lemmon H, Duthie SJ, Collins AR, Crawford JR (2011) How the 1932 and 1947 mental surveys of Aberdeen schoolchildren provide a framework to explore the childhood origins of late onset disease and disability. Maturitas 69:365–372PubMedCrossRefGoogle Scholar
  124. Whalley LJ, Staff RT, Murray AD, Deary IJ, Starr JM (2013) Genetic and environmental factors in late onset dementia: possible role for early parental death. Int J Geriatr Psychiatry 28:75–81PubMedCrossRefGoogle Scholar
  125. Wharton SB, Brayne C, Savva GM, Matthews FE, Forster G, Simpson J, Lace G, Ince PG (2011) Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience. J Alzheimers Dis 25:359–372PubMedGoogle Scholar
  126. Wu Y-T, Matthews FE, Brayne C (2014) Dementia: time trends and policy responses. Maturitas 79:191–195PubMedCrossRefGoogle Scholar
  127. Yegambaram M, Manivannan B, Beach TG, Halden RU (2015) Role of environmental contaminants in the etiology of Alzheimer’s disease: a review. Curr Alzheimer Res 12:116–146PubMedCrossRefGoogle Scholar
  128. Yoon S, Kim J-M, Kang H-J, Bae K-Y, Kim S-W, Shin I-S, Yoon J-S (2015) Associations of pulmonary function with dementia and depression in an older Korean population. Psychiatry Invest 12:443–450CrossRefGoogle Scholar
  129. Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, Feng J (2014) (11)C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 7:Cd010386Google Scholar

Copyright information

© Springer Science+Business Media Singapore 2017

Authors and Affiliations

  • Tom C. Russ
    • 1
    • 2
    • 3
    • 4
  • Craig W. Ritchie
    • 1
    • 4
  • Karen Ritchie
    • 1
    • 5
    • 6
  1. 1.Centre for Dementia PreventionUniversity of EdinburghEdinburghUK
  2. 2.Alzheimer Scotland Dementia Research CentreUniversity of EdinburghEdinburghUK
  3. 3.Centre for Cognitive Ageing and Cognitive EpidemiologyUniversity of EdinburghEdinburghUK
  4. 4.Division of PsychiatryUniversity of EdinburghEdinburghUK
  5. 5.INSERMMontpellierFrance
  6. 6.University of MontpellierMontpellierFrance

Personalised recommendations